Arca
Skip to content
Tools
Tools

Collagen

Complex group in Homo sapiens that 2 drugs act on.

  • Drugs that act on it: 2
  • Approved: 2
  • In phases 1 to 3: 0
  • Sponsors: 2
  • Genes: 25

Who is on it, and how far along

Every drug ChEMBL records acting on COL11A1, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Protein or peptide 2

Approved2

  • Collagenase clostridium histolyticum
  • Ocriplasmin

Phase 30

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        Collagenase clostridium histolyticumApprovedEndo InternationalProtein or peptideHydrolytic enzymeCollagen hydrolytic enzyme11
        OcriplasminApprovedThromboGenicsProtein or peptideHydrolytic enzymeCollagen hydrolytic enzyme0

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 8 in all, from ClinicalTrials.gov.
        Application of Autologous Adipose Stromal Vascular Fraction in the Treatment of Diminished Ovarian ReserveCollagenase clostridium histolyticumNot applicableNot yet recruitingPeking University Third HospitalOct 28, 2026
        Collagenase Injection for Spasticity ManagementCollagenase clostridium histolyticumEarly phase 1Not yet recruitingThe University of Texas Health Science Center, HoustonJul 9, 2026
        Collagenase Injection for Contracture ManagementCollagenase clostridium histolyticumEarly phase 1Not yet recruitingThe University of Texas Health Science Center, HoustonJul 9, 2026
        Delayed Dose Collagenase Clostridium Histolyticum (CCH) Protocol for Men With Peyronie's DiseaseCollagenase clostridium histolyticumPhase 4Active, not recruitingCharitable Union for the Research and Education of Peyronie's DiseaseOct 18, 2024
        Application of Autologous Adipose Stromal Vascular Fraction in the Treatment of Premature Ovarian InsufficiencyCollagenase clostridium histolyticumNot applicableRecruitingRui YangJul 1, 2024
        Radiation Therapy for Dupuytren's Contracture Following Non-Surgical ReleaseCollagenase clostridium histolyticumNot applicableRecruitingDartmouth-Hitchcock Medical CenterMar 26, 2024
        Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's DiseaseCollagenase clostridium histolyticumNot applicableRecruitingMayo ClinicOct 4, 2023
        Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's DiseaseCollagenase clostridium histolyticumPhase 4Active, not recruitingUniversity of MiamiMar 20, 2023

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2364188, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.